{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T06:15:58Z","timestamp":1790403358476,"version":"4.1.0"},"reference-count":43,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2015,8,21]],"date-time":"2015-08-21T00:00:00Z","timestamp":1440115200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Movement Disorders"],"published-print":{"date-parts":[[2016,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Objectives<\/jats:title><jats:p>The Parkinson Associated Risk Syndrome Study identified a cohort of healthy adults with hyposmia and dopamine transporter binding reduction to characterize individuals at risk for Parkinson's disease (PD). We describe the cognitive profile of this cohort.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Individuals older than 50 y without PD were recruited. Two hundred twenty\u2010five completed cognitive testing and were included in the final analysis. A neuropsychological test battery was administered and normative scores created for global cognition, memory, executive function\/working memory, processing speed\/attention, visuospatial abilities, and language domains. Other non\u2010motor symptoms (constipation, depression, anxiety, and rapid eye movement sleep behavior disorder) were assessed through questionnaires.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Individuals with both hyposmia and reduced dopamine transporter binding (n\u2009=\u200938) had lower mean scores for global cognition, executive function\/working memory, and memory compared with all other participants (n\u2009=\u2009187). In separate multivariate logistic regression models, lower global cognition (odds ratio, 1.97, <jats:italic>P<\/jats:italic>\u2009=\u20090.004), and specifically executive function\/working memory (odds ratio, 1.84, <jats:italic>P<\/jats:italic>\u2009=\u20090.004) scores were associated with membership in the hyposmia with dopamine transporter reduction group. Combining hyposmia with relative impairment on specific cognitive domains increased the odds of dopamine transporter binding reduction compared with hyposmia alone, with the greatest increase in odds for hyposmia plus executive function\/working memory relative impairment (68% increase in odds from 4.14 to 6.96).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Changes in global cognitive abilities, and specifically executive function\/working memory, are present in individuals at risk for PD. Combining non\u2010motor features, including cognition, improves prediction of dopamine transporter binding reduction. \u00a9 2015 International Parkinson and Movement Disorder Society<\/jats:p><\/jats:sec>","DOI":"10.1002\/mds.26373","type":"journal-article","created":{"date-parts":[[2015,8,21]],"date-time":"2015-08-21T04:29:39Z","timestamp":1440131379000},"page":"86-94","source":"Crossref","is-referenced-by-count":99,"title":["Cognition in individuals at risk for Parkinson's: Parkinson associated risk syndrome (PARS) study findings"],"prefix":"10.1002","volume":"31","author":[{"given":"Lama M.","family":"Chahine","sequence":"first","affiliation":[{"name":"Department of Neurology Perelman School of Medicine at the University of Pennsylvania Philadelphia Pennsylvania USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Weintraub","sequence":"additional","affiliation":[{"name":"Department of Neurology Perelman School of Medicine at the University of Pennsylvania Philadelphia Pennsylvania USA"},{"name":"Department of Psychiatry Perelman School of Medicine at the University of Pennsylvania Philadelphia Pennsylvania USA"},{"name":"PD Research, Education and Clinical Center Philadelphia Veterans Affairs Medical Center Philadelphia Pennsylvania USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith A.","family":"Hawkins","sequence":"additional","affiliation":[{"name":"Department of Psychiatry Yale University School of Medicine New Haven Connecticut USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Siderowf","sequence":"additional","affiliation":[{"name":"Avid Radiopharmaceuticals Philadelphia Pennsylvania USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shirley","family":"Eberly","sequence":"additional","affiliation":[{"name":"Department of Biostatistics University of Rochester School of Medicine Rochester New York USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Oakes","sequence":"additional","affiliation":[{"name":"Department of Biostatistics University of Rochester School of Medicine Rochester New York USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Seibyl","sequence":"additional","affiliation":[{"name":"The Institute for Neurodegenerative Disorders New Haven Connecticut USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew B.","family":"Stern","sequence":"additional","affiliation":[{"name":"Department of Neurology Perelman School of Medicine at the University of Pennsylvania Philadelphia Pennsylvania USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth","family":"Marek","sequence":"additional","affiliation":[{"name":"The Institute for Neurodegenerative Disorders New Haven Connecticut USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danna","family":"Jennings","sequence":"additional","affiliation":[{"name":"The Institute for Neurodegenerative Disorders New Haven Connecticut USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the PARS Investigators","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2015,8,21]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/114.5.2283"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrneurol.2014.226"},{"issue":"2","key":"e_1_2_8_4_1","first-page":"S139","article-title":"Premotor Parkinson's disease: clinical features, detection, and prospects for treatment","volume":"64","author":"Siderowf A","year":"2008","journal-title":"Ann Neurol"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1002\/mds.24892"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.57.3.456"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3182a956ad"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0404.2006.00579.x"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0089741"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1002\/mds.26170"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000338632.00552.cb"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000286943.79593.a6"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000000960"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/0031-9384(84)90269-5"},{"issue":"4","key":"e_1_2_8_15_1","first-page":"A136","article-title":"A sensitive and specific screening method for Parkinsons disease","volume":"44","author":"Tanner CM","year":"1990","journal-title":"Neurology"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.51.2.526"},{"key":"e_1_2_8_17_1","volume-title":"Manual for the state\u2010trait anxiety inventory (form Y)","author":"Spielberger CD","year":"1983"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.2044-8260.1983.tb00610.x"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.2190\/LYKR-7VHP-YJEM-MKM2"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410380407"},{"key":"e_1_2_8_21_1","first-page":"1500","article-title":"Iodine\u2010123\u2010beta\u2010CIT and iodine\u2010123\u2010FPCIT SPECT measurement of dopamine transporters in healthy subjects and Parkinson's patients","volume":"39","author":"Seibyl JP","year":"1998","journal-title":"J Nucl Med"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.1097\/00019442-200201000-00005"},{"key":"e_1_2_8_23_1","volume-title":"The Hopkins verbal learning test\u2014revised","author":"Brandt J","year":"2001"},{"key":"e_1_2_8_24_1","volume-title":"Repeatable battery for the assessment of neuropsychological status","author":"Randolph C","year":"1998"},{"key":"e_1_2_8_25_1","volume-title":"Wechsler memory scale","author":"Wechsler D","year":"1997"},{"key":"e_1_2_8_26_1","volume-title":"A Compendium of Neuropsychological Tests: Administration, Norms and Commentary","author":"Spreen O","year":"1998"},{"key":"e_1_2_8_27_1","volume-title":"Manual of directions and scoring","author":"Army Individual Test Battery","year":"1944"},{"key":"e_1_2_8_28_1","volume-title":"TVPS(UL)\u2010R: Test of Visual\u2010Perceptual Skills (Non motor) (Upper Level) Revised","author":"Gardner MF","year":"1997"},{"key":"e_1_2_8_29_1","volume-title":"Visual object and space perception battery (VOSP)","author":"Warrington EK","year":"1991"},{"key":"e_1_2_8_30_1","volume-title":"Boston Naming Test","author":"Kaplan E","year":"1983"},{"key":"e_1_2_8_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2008.07.008"},{"key":"e_1_2_8_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1353-8020(11)70062-1"},{"key":"e_1_2_8_33_1","doi-asserted-by":"publisher","DOI":"10.1111\/ene.12382"},{"key":"e_1_2_8_34_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.157.9.1399"},{"key":"e_1_2_8_35_1","doi-asserted-by":"publisher","DOI":"10.1002\/mds.22534"},{"key":"e_1_2_8_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pscychresns.2004.09.005"},{"key":"e_1_2_8_37_1","doi-asserted-by":"publisher","DOI":"10.1002\/mds.25157"},{"key":"e_1_2_8_38_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0071341"},{"key":"e_1_2_8_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neubiorev.2013.05.008"},{"key":"e_1_2_8_40_1","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000191154.78131.f6"},{"key":"e_1_2_8_41_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3181b0bd3d"},{"key":"e_1_2_8_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0197-4580(02)00065-9"},{"key":"e_1_2_8_43_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00702-012-0956-y"},{"key":"e_1_2_8_44_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.21541"}],"container-title":["Movement Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fmds.26373","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fmds.26373","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/movementdisorders.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/mds.26373","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T14:35:57Z","timestamp":1760970957000},"score":1,"resource":{"primary":{"URL":"https:\/\/movementdisorders.onlinelibrary.wiley.com\/doi\/10.1002\/mds.26373"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8,21]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,1]]}},"alternative-id":["10.1002\/mds.26373"],"URL":"https:\/\/doi.org\/10.1002\/mds.26373","archive":["Portico"],"relation":{},"ISSN":["0885-3185","1531-8257"],"issn-type":[{"value":"0885-3185","type":"print"},{"value":"1531-8257","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,8,21]]}}}